These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 28600444)

  • 21. Mirtazapine improves visual hallucinations in Parkinson's disease: a case report.
    Tagai K; Nagata T; Shinagawa S; Tsuno N; Ozone M; Nakayama K
    Psychogeriatrics; 2013 Jun; 13(2):103-7. PubMed ID: 23909968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parkinson's disease psychosis: presentation, diagnosis and management.
    Schneider RB; Iourinets J; Richard IH
    Neurodegener Dis Manag; 2017 Dec; 7(6):365-376. PubMed ID: 29160144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visual hallucinations and cognitive impairment in Parkinson's disease.
    Park HK; Kim JS; Im KC; Kim MJ; Lee JH; Lee MC; Kim J; Chung SJ
    Can J Neurol Sci; 2013 Sep; 40(5):657-62. PubMed ID: 23968938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of psychosis in Parkinson's disease.
    Fénelon G; Alves G
    J Neurol Sci; 2010 Feb; 289(1-2):12-7. PubMed ID: 19740486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropsychological correlates of mild to severe hallucinations in Parkinson's disease.
    Llebaria G; Pagonabarraga J; Martínez-Corral M; García-Sánchez C; Pascual-Sedano B; Gironell A; Kulisevsky J
    Mov Disord; 2010 Dec; 25(16):2785-91. PubMed ID: 20960483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hallucinations and the spectrum of psychosis in Parkinson's disease.
    Frei K; Truong DD
    J Neurol Sci; 2017 Mar; 374():56-62. PubMed ID: 28108020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency and Characteristics of Psychosis in Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Chendo I; Silva C; Duarte GS; Prada L; Voon V; Ferreira JJ
    J Parkinsons Dis; 2022; 12(1):85-94. PubMed ID: 34806620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Psychosis in Parkinson's disease].
    Rongve A; Auning E; Ehrt U; Arsland D
    Tidsskr Nor Laegeforen; 2012 Jan; 132(2):155-8. PubMed ID: 22278271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disruption of the default mode network and its intrinsic functional connectivity underlies minor hallucinations in Parkinson's disease.
    Bejr-Kasem H; Pagonabarraga J; Martínez-Horta S; Sampedro F; Marín-Lahoz J; Horta-Barba A; Aracil-Bolaños I; Pérez-Pérez J; Ángeles Botí M; Campolongo A; Izquierdo C; Pascual-Sedano B; Gómez-Ansón B; Kulisevsky J
    Mov Disord; 2019 Jan; 34(1):78-86. PubMed ID: 30536829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychosis in Parkinson's disease.
    Thanvi BR; Lo TC; Harsh DP
    Postgrad Med J; 2005 Oct; 81(960):644-6. PubMed ID: 16210460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three presenile patients in which neuropsychological and neuroimaging examinations suggest possible progression to dementia with Lewy bodies.
    Ota K; Iseki E; Murayama N; Chiba Y; Fujishiro H; Kasanuki K; Manabe Y; Arai H; Sato K
    Psychogeriatrics; 2014 Mar; 14(1):72-80. PubMed ID: 24528622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychosis in Parkinson's Disease: A Lesson from Genetics.
    Angelopoulou E; Bougea A; Papageorgiou SG; Villa C
    Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective study of hallucinations and delusions in Parkinson's disease.
    Holroyd S; Currie L; Wooten GF
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):734-8. PubMed ID: 11385005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychotic symptoms complicate the clinical differentiation of Parkinson's disease with major depressive disorder from dementia with Lewy bodies.
    Miyashita M; Sasayama D; Sugiyama N; Yasaki T; Washizuka S; Amano N
    Psychogeriatrics; 2010 Jun; 10(2):107-11. PubMed ID: 20738816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prevalence and characteristics of hallucinations, delusions and minor phenomena in a non-demented population sample aged 60 years and over.
    Soulas T; Cleret de Langavant L; Monod V; Fénelon G
    Int J Geriatr Psychiatry; 2016 Dec; 31(12):1322-1328. PubMed ID: 26876683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hallucinations, somatic-functional disorders of PD-DLB as expressions of thalamic dysfunction.
    Onofrj M; Espay AJ; Bonanni L; Delli Pizzi S; Sensi SL
    Mov Disord; 2019 Aug; 34(8):1100-1111. PubMed ID: 31307115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visual hallucinations in photographs in Parkinson's disease.
    Vaou O; Saint-Hilaire M; Friedman J
    BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23704424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors.
    Fénelon G; Mahieux F; Huon R; Ziégler M
    Brain; 2000 Apr; 123 ( Pt 4)():733-45. PubMed ID: 10734005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural and functional neuroimaging in patients with Parkinson's disease and visual hallucinations: A critical review.
    Lenka A; Jhunjhunwala KR; Saini J; Pal PK
    Parkinsonism Relat Disord; 2015 Jul; 21(7):683-91. PubMed ID: 25920541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychosis in Parkinson's disease: From the soft signs to the hard science.
    Lenka A; Herath P; Christopher R; Pal PK
    J Neurol Sci; 2017 Aug; 379():169-176. PubMed ID: 28716235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.